Menu

Caribou Biosciences, Inc. CRBU

Full chart Compare
Set alert

Price alert · CRBU

All alert types
0.41 USD -0.01 (-2.24%)

At closeNov 10, 2026, 7:06 PM EST

0.41 0.00 -0.56%

After hours · Nov 10, 7:06 PM ET

0.3902 Day range 0.4298
0.3902 52-week range 2.49
YTD
-74.19%
1 year
-80.17%

Revenue & Expenses

Revenue by
Other Operating Income → Expenses: $3.65MIncome Tax Benefit → Expenses: $550.00KExpenses → Selling, General & Admin: $37.91MExpenses → Research & Development: $109.44MExpenses → Other Expenses: $12.48MUnited States → Revenue: $9.48MGross Profit → Expenses: $7.51MRevenue → Gross Profit: $7.51MRevenue → Cost of Revenue: $3.65MNon-US → Revenue: $1.68MNet Loss → Expenses: $148.13MOther Operating Income$3.65MIncome Tax Benefit$550.00KGross Profit$7.51MNet Loss$148.13MCost of Revenue$3.65MExpenses$159.83MSelling, General & Admin$37.91MResearch & Development$109.44MOther Expenses$12.48MRevenue$11.16MUnited States$9.48MNon-US$1.68M

Latest period ending Dec 31, 2025 · select a line to chart its full history

CRBU annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
11.16M9.99M34.48M13.85M9.60M
11.16M9.99M34.48M13.85M9.60M
-148.34M-166.62M-116.06M-106.40M-66.98M
-148.13M-149.10M-102.07M-99.42M-66.92M
-1.59-1.65-1.38-1.64-2.11
CRBU annual balance sheet
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
12.36M16.29M51.16M58.34M240.42M
175.37M313.31M432.21M373.76M442.36M
53.19M60.36M63.81M72.89M54.53M
27.23M26.49M27.11M27.75M0
122.17M252.95M368.40M300.87M387.82M
CRBU annual cash flow
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
-110.99M-138.20M-93.29M-90.97M-32.52M
102.24M86.61M-68.18M-93.25M-176.40M
4.82M16.72M154.30M2.13M433.43M
-1.36M-4.87M-11.61M-6.45M-2.12M
-3.93M-34.87M-7.18M-182.08M224.51M